Back

Tissue inhibitor of metalloproteinase (TIMP)-1 predicts negative remodeling and recovery of ejection fraction in acute heart failure with reduced ejection fraction.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Acute heart failure - Biomarkers Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Chih Hsueh Tseng

Taipei Veterans General Hospital, Taipei (Taiwan)

7 More presentations in this session

Presentation thumbnail
Remote dielectric sensing detects pulmonary congestion in emergency patients with dyspnoea
Doctor A. Olesen (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Relation of lymphopenia to comorbidity burden and its prognostic value in patients with acute decompensated heart failure with preserved left ventricular ejection fraction: a multicentre study
Mr S. Tamaki (Toon, JP)
Abstract Slides
Presentation thumbnail
Derivation and validation of a machine learning-based risk prediction model for in-hospital mortality in patients with acute heart failure.
Doctor K. Misumi (Fukuoka, JP)
Abstract Slides
Presentation thumbnail
Relationship between GDF-15, urinary sodium and markers of renal function in patients with chronic heart failure
Doctor G. Moreira (Niteroi, BR)
Abstract Slides
Presentation thumbnail
Characterization and prognostic relevance of neuron specific enolase (NSE) after cardiopulmonary resuscitation (CPR) with extracorporeal circulation (e - CPR)
Doctor F. Haertel (Jena, DE)
Abstract Slides

Access the full session

Session thumbnail
Acute heart failure - Biomarkers

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Presentation
Novel concepts in the diagnosis of AHF in the emergency department
thumbnail
Congress Presentation
Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources